Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-24 @ 6:59 PM
NCT ID:
NCT07040657
Eligibility Criteria:
Inclusion Criteria:
* Individuals diagnosed with stage I endometrial cancer based on CT and PET-CT imaging.
* Individuals with a pathologically confirmed diagnosis of stage I endometrial cancer.
Exclusion Criteria:
Medical Conditions
* Individuals diagnosed with dementia.
* Individuals with allergies to methylene blue or iodine.
* Individuals who have received active treatment for another malignancy within the past five years.
* Inability to successfully perform PLD (pelvic lymphadenectomy) or history of prior PLD.
* Women with multiple and confluent lymph nodes identified as positive on FDG-PET/CT (such cases are not considered stage I).
Cancer-Related Conditions
* Individuals with clinically or radiologically identified positive lymph nodes or metastatic disease.
* Individuals with a history of pelvic dissection and/or radiation therapy.
* Individuals with advanced cervical or uterine cancer.
* Individuals with T3/T4 lesions.
* Individuals with cervical tumors larger than 2 cm.
Organ Dysfunction
• Individuals with hepatic dysfunction and a MELD score ≥ 10 and creatinine ≥ 2·0 mg/dl patients.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07040657
Study Brief:
Protocol Section:
NCT07040657